Industry Developments

BMI View: As BMI has previously warned, the Ukrainian government is now getting serious in its plans for greater control of drug prices in the domestic market. However, drug policy... 2012-03-05

BMI View: Drugmakers operating in Hungary should be concerned by the latest comments from an important member of Hungary's Fidesz party that indicate the government may be preparing... 2012-02-29

BMI View: Corruption continues to be a major problem within state healthcare services in Serbia. The government are taking measures to tackle the issue but the pharmaceutical industry... 2012-02-29

BMI View: In the weeks to come, it is likely that the Bulgarian authorities will announce a series of price reductions for pharmaceuticals sold in the country, which will be achieved... 2012-02-28

BMI View: Moldova's pharmaceutical market recorded stronger growth in 2011 than in 2010, but the market's small size and the fact that it is the poorest country in Europe limit its... 2012-02-17

BMI View: It is worth reiterating our view that while 2012 is set to be a challenging year for drugmakers operating in Poland, we do not believe the impact of the Drug Reimbursement... 2012-02-09

BMI View: The surprise resignation of Romanian prime minister Emil Boc and his government on February 6 is very bad news for private healthcare insurers, which just a month ago were... 2012-02-07

BMI View: Greece's failure to aggressively cut public pharmaceutical expenditure in 2011 means these savings will have to be achieved in 2012, placing additional pressure on the already... 2012-02-06

BMI View: It is clear that the Czech Republic pharmaceutical and healthcare market will be under intense pressure in 2012, the combination of drug policy reforms and a weak economic... 2012-02-02

BMI View: The long-awaited conclusion of the final part of a deal between Stada and Grunenthal is good news for both firms. An immediate cash injection for Grunenthal should support... 2012-02-02